Cancer Biology and Immunology - A Division-wide, Open-rank Faculty Search #BSD041

Description

Scope and Opportunity

The University of Chicago's Biological Sciences Division is searching for full-time scientists, physician-scientists, and engineers whose work will help define the next generation of cancer biology and immunology.

We are especially interested in candidates whose research illuminates the dynamic biology of malignant cells, immune cells, tissue environments, host physiology, microbes, metabolism, and therapeutic intervention in cancer. Researchers in immune-related diseases, such as autoimmunity, infection biology, transplantation immunology, immune tolerance, and inflammation are also encouraged to apply.

Academic rank, track, tenure status, and compensation are dependent upon qualifications. Primary appointments will be in appropriate departments or units, most likely in the Biological Sciences Division, though potentially in the Physical Sciences Division, or the Pritzker School of Molecular Engineering, with possible secondary appointments in other relevant units depending on the candidates' research.

These positions are benefits eligible. The University of Chicago offers a wide range of benefits programs and resources for eligible employees, including health, retirement, and paid time off. Information about the benefit offerings can be found in the Benefits Guidebook. 

Appointees will join a highly collaborative academic ecosystem in which outstanding basic science and clinical departments are co-located on a compact urban campus, with state-of-the-art core facilities, exceptional graduate and medical students, and opportunities to participate in multidisciplinary research, translation, commercialization, and entrepreneurship, including Hyde Park Labs, a new hybrid facility for academic research, science-based companies and the UChicago Science Incubator.

 

Research Priorities

The goal of this search is to recruit faculty who will deepen and expand the University of Chicago’s strengths in cancer biology, immunology, or immuno-oncology, while building new connections among basic scientists, clinicians, engineers, computational biologists, public health and translational investigators.

Areas of interest include, but are not limited to:

 ·       Tumor microenvironment and cancer–immune ecology

·       Cancer metabolism or immunometabolism

·       T-cell, NK-cell, B-cell, and myeloid-cell biology

·       Microbiome, virome, and host–microbe interactions

·       Tissue immunity in inflammation and/or tumor biology

·       Cancer initiation, progression, metastasis, dormancy, recurrence, and immune escape

·       Aging and immunosenescence in cancer

·       Neuroimmune regulation in cancer and immunity

·       Spatial, systems, and computational cancer or immunology

·       Single-cell, functional-genomic, proteomic, metabolomic, or imaging approaches to cancer and/or immunity

·       Immune monitoring, biomarker discovery, and mechanisms of therapeutic response or resistance

·       Vaccines, antigen discovery, antigen presentation, and immune recognition

·       Engineered immunity, synthetic immunology, and cell-based therapies, including CAR, TCR, NK-cell, and gene-edited immune-cell platforms

·       Antibody therapeutics, bispecifics, immune checkpoints, and other immune-modulating strategies

Candidates with program